The expression of the proto-oncogene Kras in the pancreas activates the Stat3/Socs3 signaling pathway, which relies on IL-6 and its downstream signaling pathways, ultimately promoting pancreatic cancer development. This evidence concerns the gene KRAS and pancreatic neoplasm.